Joel Lewis, Director at GALECTIN THERAPEUTICS INC (GALT), bought 25,698 shares at $4.28 ($110K) on 2019-05-31, disclosed to the SEC on 2019-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.28 | 12,849 | $55K | 50.0% |
| 2 | $4.28 | 12,849 | $55K | 50.0% |
| Total | $4.28 avg | 25,698 | $110K | 100% |
| Filing → |
| GALT | SELL | 2025-11-19 | $231K | — | Filing → |
| GALT | SELL | 2025-11-12 | $11K | — | Filing → |
| GALT | SELL | 2025-11-07 | $1K | — | Filing → |